Welcome to LookChem.com Sign In|Join Free
  • or
1-[3-(4-amino-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-phenyl]-3-(2-methoxy-5-methyl-phenyl)-urea is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

717899-12-2

Post Buying Request

717899-12-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

717899-12-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 717899-12-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,7,8,9 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 717899-12:
(8*7)+(7*1)+(6*7)+(5*8)+(4*9)+(3*9)+(2*1)+(1*2)=212
212 % 10 = 2
So 717899-12-2 is a valid CAS Registry Number.

717899-12-2Downstream Products

717899-12-2Relevant academic research and scientific papers

Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors

Arcari, Joel T.,Beebe, Jean S.,Berliner, Martin A.,Bernardo, Vincent,Boehm, Merin,Borzillo, Gary V.,Clark, Tracey,Cohen, Bruce D.,Connell, Richard D.,Frost, Heather N.,Gordon, Deborah A.,Hungerford, William M.,Kakar, Shefali M.,Kanter, Aaron,Keene, Nandell F.,Knauth, Elizabeth A.,Lagreca, Susan D.,Lu, Yong,Martinez-Alsina, Louis,Marx, Matthew A.,Morris, Joel,Patel, Nandini C.,Savage, Doug,Soderstrom, Cathy I.,Thompson, Carl,Tkalcevic, George,Tom, Norma J.,Vajdos, Felix F.,Valentine, James J.,Vincent, Patrick W.,Wessel, Matthew D.,Chen, Jinshan M.

, p. 3059 - 3063 (2013/06/27)

The synthesis and biological evaluation of novel Tie-2 kinase inhibitors are presented. Based on the pyrrolopyrimidine chemotype, several new series are described, including the benzimidazole series by linking a benzimidazole to the C5-position of the 4-a

PYRROLOPYRIMIDINE DERIVATIVES

-

Page 111, (2010/02/07)

The invention relates to compounds of the formula 1or a pharmaceutically acceptable salt, prodrug or hydrates thereof, wherein Q, A, L, R1, R2 and R3 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 717899-12-2